Ascendant Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$6.14M |
| 2 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$3.54M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$3.53M |
| 4 |
Invesco Taxable Municipal Bond ETF
BAB
|
+$3.19M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$2.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$2.45M |
| 2 |
Northrop Grumman
NOC
|
+$1.64M |
| 3 |
Invesco Senior Loan ETF
BKLN
|
+$1.35M |
| 4 |
Eli Lilly
LLY
|
+$1.1M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.4% |
| 2 | Consumer Discretionary | 12.04% |
| 3 | Financials | 3.72% |
| 4 | Communication Services | 3.36% |
| 5 | Materials | 2.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
O'Reilly Automotive
ORLY
$71.3B
| – | – |
-15,000
| Closed | -$844K |
|
77
Regeneron Pharmaceuticals
REGN
$70.9B
| – | – |
-500
| Closed | -$361K |
|
78
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| – | – |
-500
| Closed | -$349K |
|
79
UnitedHealth
UNH
$387B
| – | – |
-1,500
| Closed | -$795K |
|
80
United Therapeutics
UTHR
$22.7B
| – | – |
-2,000
| Closed | -$556K |
|
81
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-1,300
| Closed | -$375K |
|
|
82
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| – | – |
-12,500
| Closed | -$1.04M |
|
|
83
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| – | – |
-18,000
| Closed | -$2.45M |
|
Similar funds
Ascendant Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Ascendant Capital Management held 83 positions worth $75.7M, up 126% from $33.5M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Ascendant Capital Management deployed $37.2M of net new capital in Q1 2023, opening 41 new positions and adding to 11 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 67,000 shares worth $6.15M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was VanEck Fallen Angel High Yield Bond ETF, an estimated $414K trimmed.
- Ascendant Capital Management's largest Q1 2023 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 67,000 shares worth $6.15M.
- Ascendant Capital Management added most to iShares National Muni Bond ETF in Q1 2023, an estimated $1.71M increase.
- Ascendant Capital Management's biggest Q1 2023 reduction was VanEck Fallen Angel High Yield Bond ETF, cutting an estimated $414K.
- Ascendant Capital Management fully exited State Street Health Care Select Sector SPDR ETF in Q1 2023, selling an estimated $2.45M.
- Ascendant Capital Management's ten largest holdings make up 41% of its $75.7M portfolio in Q1 2023.
- Ascendant Capital Management opened 41 new positions and closed 24 in Q1 2023.
- Ascendant Capital Management's portfolio value rose 126% quarter-over-quarter to $75.7M.
Based on Ascendant Capital Management's 13F filing for Q1 2023, filed 15 May 2023.